Correlation Between Takeda Pharmaceutical and Neurocrine Biosciences
Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Takeda Pharmaceutical Co and Neurocrine Biosciences, you can compare the effects of market volatilities on Takeda Pharmaceutical and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and Neurocrine Biosciences.
Diversification Opportunities for Takeda Pharmaceutical and Neurocrine Biosciences
-0.11 | Correlation Coefficient |
Good diversification
The 3 months correlation between Takeda and Neurocrine is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical Co and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical Co are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and Neurocrine Biosciences go up and down completely randomly.
Pair Corralation between Takeda Pharmaceutical and Neurocrine Biosciences
Considering the 90-day investment horizon Takeda Pharmaceutical Co is expected to under-perform the Neurocrine Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Takeda Pharmaceutical Co is 1.87 times less risky than Neurocrine Biosciences. The stock trades about -0.12 of its potential returns per unit of risk. The Neurocrine Biosciences is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 12,510 in Neurocrine Biosciences on August 31, 2024 and sell it today you would earn a total of 149.00 from holding Neurocrine Biosciences or generate 1.19% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Takeda Pharmaceutical Co vs. Neurocrine Biosciences
Performance |
| Timeline |
| Takeda Pharmaceutical |
| Neurocrine Biosciences |
Takeda Pharmaceutical and Neurocrine Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Takeda Pharmaceutical and Neurocrine Biosciences
The main advantage of trading using opposite Takeda Pharmaceutical and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.| Takeda Pharmaceutical vs. Emergent Biosolutions | Takeda Pharmaceutical vs. Bausch Health Companies | Takeda Pharmaceutical vs. Neurocrine Biosciences | Takeda Pharmaceutical vs. Teva Pharma Industries |
| Neurocrine Biosciences vs. Emergent Biosolutions | Neurocrine Biosciences vs. Bausch Health Companies | Neurocrine Biosciences vs. Teva Pharma Industries | Neurocrine Biosciences vs. Haleon plc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |